.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Cantor Fitzgerald
McKinsey
Federal Trade Commission
Daiichi Sankyo
Farmers Insurance
Baxter
QuintilesIMS
Cipla
Julphar

Generated: January 17, 2018

DrugPatentWatch Database Preview

Patents Expiring in January 2021

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
AllerganLATISSEbimatoprostSOLUTION/DROPS;TOPICAL022369-001Dec 24, 2008ATRXYesYes➤ Subscribe➤ SubscribeMETHOD OF INCREASING HAIR GROWTH
AllerganLATISSEbimatoprostSOLUTION/DROPS;TOPICAL022369-001Dec 24, 2008ATRXYesYes➤ Subscribe➤ SubscribeMETHOD OF INCREASING HAIR GROWTH
AllerganLATISSEbimatoprostSOLUTION/DROPS;TOPICAL022369-001Dec 24, 2008ATRXYesYes➤ Subscribe➤ Subscribe
Organon Sub MerckBRIDIONsugammadex sodiumSOLUTION;INTRAVENOUS022225-001Dec 15, 2015RXYesYes➤ Subscribe➤ SubscribeREVERSAL OF NEUROMUSCLUAR BLOCKAGE INDUCED BY ROCURONIUM BROMIDE OR VECURONIUM BROMIDE
Organon Sub MerckBRIDIONsugammadex sodiumSOLUTION;INTRAVENOUS022225-001Dec 15, 2015RXYesYes➤ Subscribe➤ SubscribeYYREVERSAL OF DRUG-INDUCED NEUROMUSCLUAR BLOCK
Organon Sub MerckBRIDIONsugammadex sodiumSOLUTION;INTRAVENOUS022225-002Dec 15, 2015RXYesNo➤ Subscribe➤ SubscribeYYREVERSAL OF DRUG-INDUCED NEUROMUSCLUAR BLOCK
Organon Sub MerckBRIDIONsugammadex sodiumSOLUTION;INTRAVENOUS022225-002Dec 15, 2015RXYesNo➤ Subscribe➤ SubscribeREVERSAL OF NEUROMUSCLUAR BLOCKAGE INDUCED BY ROCURONIUM BROMIDE OR VECURONIUM BROMIDE
Eisai IncHALAVENeribulin mesylateSOLUTION;INTRAVENOUS201532-001Nov 15, 2010RXYesYes➤ Subscribe➤ SubscribeTREATMENT OF PATIENTS WITH METASTATIC BREAST CANCER
Novo Nordisk IncNOVOLOG MIX 70/30 FLEXPENinsulin aspart protamine recombinant; insulin aspart recombinantINJECTABLE;SUBCUTANEOUS021172-004May 3, 2002RXYesYes➤ Subscribe➤ SubscribeY
Novo Nordisk IncNOVOLOG FLEXPENinsulin aspart recombinantINJECTABLE;SUBCUTANEOUS020986-003Jan 19, 2001RXYesYes➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Cipla
AstraZeneca
Moodys
Citi
Dow
Novartis
Fish and Richardson
Federal Trade Commission
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot